The Organisation for Economic Co-operation and Development (OECD) has recently published the first five adverse outcome pathways (AOP), three of which have been developed by the JRC. The AOPs are novel knowledge management tools in toxicology and are useful for supporting risk assessment to human health. They are also valuable for helping to avoid animal testing through the use of alternative methods.
An adverse outcome pathway, or AOP, is a highly structured way of describing a toxicological process which can lead to an adverse health effect in humans or wildlife, caused by an unsafe exposure to a chemical substance. Essentially an AOP tells a toxicological story in terms of a logical sequence of causally-linked ‘key events’ that occur at different levels of biological organisation, from perturbations at the molecular scale up to effects occurring in a whole organism or a population. The AOPs developed by the JRC, now published by OECD, relate to chemical-induced liver fibrosis, aspects of neurotoxicity in adults, and certain neurotoxicological effects that can be caused during human development.
AOP development process
The AOP framework has been developed through an extensive international collaboration between scientists, regulators and policy-makers with the primary goal of making mechanistic toxicological knowledge more readily available to support safety assessment decisions. AOPs are essential in the process of shifting from traditional animal testing to new non-animal approaches that are based on the combination of in vitro methods and computational modelling. The AOPs are available in the new OECD Series on Adverse Outcome Pathways. The development process followed the relevant OECD guidance.
At the OECD, the Extended Advisory Group for Molecular Screening and Toxicogenomics (co-chaired by the JRC on behalf of the EU) manages the development of AOPs which undergo a series of expert reviews before being submitted for endorsement to the Working Group of National Coordinators for the Test Guidelines Programme (WNT) and the Task Force for Hazard Assessment. Although the AOPs developed until now have addressed chemical toxicity, the approach also lends itself to describing the mechanistic basis to potential adverse effects caused by nanomaterials, as demonstrated very recently by the JRC.
AOP Knowledge Base
The JRC has also partnered with the OECD and the US Environmental Protection Agency to develop the publically accessible AOP Knowledge Base. This key resource facilitates the scientific crowdsourcing and on-line peer review foreseen in the AOP development process and allows an AOP to continue to evolve as understanding of the underlying science grows. Once an AOP reaches a certain level of maturity, it is versioned as a document and published in the new OECD series to encourage its utilisation in non-animal species-relevant approaches to regulatory safety assessment.
This novel knowledge management framework, which is already transforming the world of toxicology, has the potential to penetrate other fields such as biomedical research, where effective translation of mechanistic understanding into application is central to innovation and progress.
The Latest on: Non-animal testing methods
via Google News
The Latest on: Non-animal testing methods
- More holistic approach needed for alternative methods in advancing safety assessment on December 7, 2018 at 3:11 am
At the 14 th Annual Conference of the EPAA (European Partnership for Alternative Approaches to Animal Testing), I was invited to host ... The development and validation of non-animal alternatives can ... […]
- LeanLife Samples Testing on December 4, 2018 at 4:49 pm
VANCOUVER, British Columbia, Dec. 04, 2018 (GLOBE NEWSWIRE) -- LeanLife Health Inc. (the “Company” or “LeanLife”) (CSE: LLP) announces results of in-house testing of various product ... […]
- EU still leads the way on animal testing alternatives, industry representative says on November 30, 2018 at 7:52 am
Is Europe still leading the way when it comes to alternative methods to animal testing? Indeed, for more than 20 years ... and companies are required to conduct animal and non-animal tests to have acc... […]
- UWindsor gets $1M donation to find other methods to animal testing on October 30, 2018 at 7:33 am
The largest research donation in University of Windsor history is supporting alternative methods to animal testing ... States—have already established national centres to advance non-animal methodolog... […]
- 400,000 Animals Are Being Killed For Botox Testing Every Year! We Need to Stop This on October 24, 2018 at 7:48 am
The paper points out the positive developments in non-animal testing methods applicable to botox products, including a cell-based assay which has been validated by the pharmaceutical company Allergan ... […]
- The big problem with the California bill that bans cosmetic animal testing on September 11, 2018 at 5:00 am
non-animal testing methods and then getting them accepted by regulators around the world. We invite you to learn more about our efforts at [PG.com]” So why is China such a big deal in cosmetic animal ... […]
- States are stepping up to end animal testing in cosmetics while federal legislation stalls on August 17, 2018 at 1:39 pm
These bills are a response to growing public opposition to animal testing, the availability of modern non-animal testing methods, and a desire for the US to match progress seen in other countries. Acc... […]
- Developing Alternatives to Animal Testing on June 26, 2018 at 5:00 pm
develop and raise awareness of alternatives methods that will help us meet our common goal; promote and expedite the development, validation and regulatory acceptance of non-animal test methods; work ... […]
- US EPA drafts approach to non-animal testing for skin sensitisation on April 12, 2018 at 4:19 am
The US EPA has outlined how it thinks non-animal (alternative) test methods for determining skin sensitisation should be used. In an interim science policy document, released on 4 April for public com... […]
via Bing News